D-1255-2020 Class I Terminated

Recalled by Avet Pharmaceuticals, Inc. — East Brunswick, NJ

FDA drug recall D-1255-2020 was initiated by Avet Pharmaceuticals, Inc. on Mar 23, 2020 and is designated Class I. Reason for recall: Failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl capsules. The recall status is terminated (terminated Aug 23, 2022). Affected quantity: 4,444 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 15, 2020
Initiation Date
Mar 23, 2020
Termination Date
Aug 23, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,444 bottles

Product description

Tetracycline HCL Capsules, USP, 250 mg, 100-count Bottle, Rx Only, Manufactured for: Heritage Pharmaceuticals Inc. East Brunswick NJ 08816. NDC 23155-017-01

Reason for recall

Failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl capsules.

Distribution pattern

Distributed Nationwide in the US

Code information

Lot # H190666, Exp JUL 2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1255-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1255-2020. Report a data issue: hello@regdatalab.com.